Advanced stage nasopharyngeal cancer (NPC) shows highly variable treatment outcomes, suggesting the need for independent prognostic factors. This study aims at developing a magnetic resonance imaging (MRI)-based radiomic signature as a prognostic marker for different clinical endpoints in NPC patients from non-endemic areas. A total 136 patients with advanced NPC and available MRI imaging (T1-weighted and T2-weighted) were selected. For each patient, 2144 radiomic features were extracted from the main tumor and largest lymph node. A multivariate Cox regression model was trained on a subset of features to obtain a radiomic signature for overall survival (OS), which was also applied for the prognosis of other clinical endpoints. Validation was performed using 10-fold cross-validation. The added prognostic value of the radiomic features to clinical features and volume was also evaluated. The radiomics-based signature had good prognostic power for OS and loco-regional recurrence-free survival (LRFS), with C-index of 0.68 and 0.72, respectively. In all the cases, the addition of radiomics to clinical features improved the prognostic performance. Radiomic features can provide independent prognostic information in NPC patients from non-endemic areas.

Baseline mri-radiomics can predict overall survival in non-endemic ebv-related nasopharyngeal carcinoma patients / M. Bologna, V. Corino, G. Calareso, C. Tenconi, S. Alfieri, N.A. Iacovelli, A. Cavallo, S. Cavalieri, L. Locati, P. Bossi, D.A. Romanello, R. Ingargiola, T. Rancati, E. Pignoli, S. Sdao, M. Pecorilla, N. Facchinetti, A. Trama, L. Licitra, L. Mainardi, E. Orlandi. - In: CANCERS. - ISSN 2072-6694. - 12:10(2020 Oct), pp. 2958.1-2958.20.

Baseline mri-radiomics can predict overall survival in non-endemic ebv-related nasopharyngeal carcinoma patients

V. Corino
Secondo
;
S. Alfieri;S. Cavalieri;R. Ingargiola;T. Rancati;E. Pignoli;S. Sdao;M. Pecorilla;L. Licitra;L. Mainardi
Penultimo
;
2020

Abstract

Advanced stage nasopharyngeal cancer (NPC) shows highly variable treatment outcomes, suggesting the need for independent prognostic factors. This study aims at developing a magnetic resonance imaging (MRI)-based radiomic signature as a prognostic marker for different clinical endpoints in NPC patients from non-endemic areas. A total 136 patients with advanced NPC and available MRI imaging (T1-weighted and T2-weighted) were selected. For each patient, 2144 radiomic features were extracted from the main tumor and largest lymph node. A multivariate Cox regression model was trained on a subset of features to obtain a radiomic signature for overall survival (OS), which was also applied for the prognosis of other clinical endpoints. Validation was performed using 10-fold cross-validation. The added prognostic value of the radiomic features to clinical features and volume was also evaluated. The radiomics-based signature had good prognostic power for OS and loco-regional recurrence-free survival (LRFS), with C-index of 0.68 and 0.72, respectively. In all the cases, the addition of radiomics to clinical features improved the prognostic performance. Radiomic features can provide independent prognostic information in NPC patients from non-endemic areas.
EBV-related nasopharyngeal carcinoma; Magnetic resonance imaging; Nasopharyngeal carcinoma; Radiomics; Survival models
Settore MED/06 - Oncologia Medica
Article (author)
File in questo prodotto:
File Dimensione Formato  
Baseline MRI.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 3.32 MB
Formato Adobe PDF
3.32 MB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/798696
Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 19
social impact